Trial Profile
The Effect of Salmeterol on Eosinophil Function.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2023
Price :
$35
*
At a glance
- Drugs Salmeterol (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Pharmacodynamics
- 02 Nov 2008 Trial end date (1 Jan 2008) added as reported by ClinicalTrials.gov.
- 02 Nov 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Nov 2005 New trial record.